Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR)

DRUG2 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

DepressionDepressive Disorder, Major Depressive DisorderMajor Depressive Disorder

Phase 2

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Child And Adolescent Outpatients With Major Depressive Disorder

CompletedNCT00619619

Wyeth is now a wholly owned subsidiary of PfizerDepression, Major Depressive Disorder

Start: 2008-02-29End: 2009-11-30Updated: 2011-02-23

Study Evaluating Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR) In The Treatment Of Child and Adolescent Outpatients With Major Depressive Disorder

CompletedNCT00669110

Wyeth is now a wholly owned subsidiary of PfizerDepressive Disorder, Major Depressive Disorder

Start: 2008-05-31End: 2010-05-31Updated: 2021-08-19